Digital PCR (dPCR) Market is expected to reach US$ 15.63 billion by 2031

Droplet Digital PCR (ddPCR) Technology Segment to Lead Digital PCR (dPCR) market During 2023–2031

According to our new research study on “Digital PCR (dPCR) market Forecast to 2031 – Global Analysis – by Technology, Component, Application, End User, and Geography,” the market was valued at US$ 6.97 billion in 2023 and is projected to reach US$ 15.63 billion by 2031; it is expected to register a CAGR of 9.9% from 2023 to 2031.

Digital polymerase chain reaction, also known as digital PCR, dPCR, digitalPCR, or dePCR, is a biotechnological modification of conventional PCR methods. dPCR is one of the leading technologies for detecting and quantifying rare mutations and target sequences. dPCR is mainly used to quantify cancer genes, track viral infection to specific bacterial cells, detect fetal DNA in circulating blood, and differentiate the expression of alleles. It is used to assess the appropriate dosages for gene and cell therapies as well as to detect circulating tumor DNA in cancer patients. Key factors driving the market growth include the increasing incidences of infectious diseases such as HIV, tuberculosis, malaria, and hepatitis. However, the high cost of instruments and the availability of alternatives, such as next-generation sequencing (NGS), hinder the growth of the Digital PCR (dPCR) market. Moreover, technological advancements in dPCR are projected to bring new Digital PCR (dPCR) market trends in the coming years.

Digital PCR (dPCR) market, by Region, 2023(%)

Source: The Insight Partners Analysis

Digital PCR (dPCR) market Analysis Based on Segmental Evaluation:

By technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR technology segment held a significant Digital PCR (dPCR) market share in 2023, and it is estimated to register a high CAGR during the forecast period. Market growth for this segment is attributed to the surging prevalence of infectious diseases such as COVID-19, HIV, latent TB infection, and TB disease. dPCR technology aids highly sensitive and specific detection and quantification of nucleic acids, which makes it a valuable tool for diagnosing infectious diseases with accuracy and reliability. This is especially crucial for detecting low viral or bacterial pathogen loads in clinical samples. dPCR allows for the simultaneous detection of multiple pathogens in a single sample, making it a versatile tool for diagnosing co-infections or different strains of a pathogen. This capability is essential for managing infectious diseases with complex etiologies or evolving variants. The growing prevalence of infectious diseases drives the demand for dPCR technology due to its high sensitivity, rapid results, multiplexing capabilities, and applications in diagnosis, treatment monitoring, research, and surveillance. Thus, the rising burden of infectious diseases worldwide propels the Digital PCR (dPCR) market growth, as this detection tool can help meet the evolving needs of healthcare systems and research communities.

Based on component, the market is segmented into instruments, reagents and consumables, and software and services. The reagents and consumables segment held a significant Digital PCR (dPCR) market share in 2023 and is estimated to register the highest CAGR during 2023–2031. Reagents and consumables—including buffers, probes, enzymes, dyes, vials, kits, and panels—are all essential parts of dPCR procedures. Several kits are available for gene expression analysis, SNP genotyping analysis, microRNA analysis, and other analyses. Growing preference for the early detection of diseases; widespread use of consumables and reagents; and expanding demand for PCRs for healthcare, research, and other purposes significantly fuel the expansion of the Digital PCR (dPCR) market size for the reagents and consumables segment.

The scope of the Digital PCR (dPCR) market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is likely to register the highest CAGR in the market from 2023 to 2031. The increasing focus on genomics research, including the study of genetic variations and gene expression profiles, is fueling the demand for dPCR platforms in Asia Pacific to facilitate high-throughput and accurate analysis. China and Japan are the major contributors to market growth in Asia Pacific. China exhibits a huge demand for high-quality healthcare products and a high prevalence of lifestyle diseases. According to the article titled “Rare Disease Day: Why China’s Rare Disease Burden Could be an Opportunity for Innovation,” published in February 2023, ~20 million Chinese people suffer from rare diseases. dPCR techniques can be used for the diagnosis and treatment of such rare conditions. Companies and research organizations in the country engage in the development of advanced diagnostics solutions. Moreover, growing diagnostic centers and hospitals, and the expanding range of medical facilities in hospitals are the factors favoring the Digital PCR (dPCR) market growth in China. dPCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT).

Thermo Fisher Scientific, Inc.; F. Hoffmann-la Roche Ltd.; QIAGEN; Akara bio, Inc.; Agilent Technologies, Inc.; Biomerieux SA; Abbott Laboratories; Merck KgaA; Promega Corporation; and BD are among the leading companies profiled in the Digital PCR (dPCR) market report.

Based on technology, the Digital PCR (dPCR) market is segmented into droplet digital PCR (ddPCR) and BEAMing digital PCR. In terms of component, the market is classified into instruments, reagents and consumables, and software and services. In terms of application, the market is categorized into clinical, research, and forensic. In terms of end user, the market is categorized into hospitals and diagnostic centers, pharmaceutical and biotech companies, research laboratories and academic institutes, forensic laboratories, and clinical research organization. Based on geography, the Digital PCR (dPCR) market is segmented into North America (US, Canada, and Mexico), Europe (France, UK, Germany, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com